Literature DB >> 22333590

Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.

Pavlina Dolezelova1, Katerina Cetkovska, Karen H Vousden, Stjepan Uldrijan.   

Abstract

Mdm2 can mediate p53 ubiquitylation and degradation either in the form of the Mdm2 homodimer or Mdm2/MdmX heterodimer. The ubiquitin ligase activity of these complexes resides mainly in their respective RING finger domains and also requires adjacent C-terminal tails. So far, structural studies have failed to show significant differences between Mdm2 RING homodimers and Mdm2/MdmX RING heterodimers. Here, we report that not only the primary amino acid sequence, but also the length of the C-terminal tail of Mdm2 is highly conserved through evolution and plays an important role in Mdm2 activity toward p53. Mdm2 mutants with extended C termini do not ubiquitylate p53 despite being capable of forming Mdm2 homodimers through both RING-acidic domain and RING-RING interactions. All extended mutants also retained the ability to interact with MdmX, and this interaction led to reactivation of their E3 ubiquitin ligase activity. In contrast, only a subset of extended Mdm2 mutants was activated by the interaction with Mdm2 RING domain, suggesting that Mdm2 homodimers and Mdm2/MdmX heterodimers may not be structurally and functionally fully equivalent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333590      PMCID: PMC3323797          DOI: 10.4161/cc.11.5.19445

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  31 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

Review 2.  RING domains: master builders of molecular scaffolds?

Authors:  K L Borden
Journal:  J Mol Biol       Date:  2000-02-04       Impact factor: 5.469

3.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

4.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

5.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

6.  The RING domain of Mdm2 can inhibit cell proliferation.

Authors:  Jinjun Dang; Mei-Ling Kuo; Christine M Eischen; Lilia Stepanova; Charles J Sherr; Martine F Roussel
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

7.  Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.

Authors:  R Stad; N A Little; D P Xirodimas; R Frenk; A J van der Eb; D P Lane; M K Saville; A G Jochemsen
Journal:  EMBO Rep       Date:  2001-10-17       Impact factor: 8.807

8.  Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.

Authors:  Jonathan Shloush; John E Vlassov; Ian Engson; Shili Duan; Vivian Saridakis; Sirano Dhe-Paganon; Brian Raught; Yi Sheng; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

9.  HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

Authors:  Laëtitia K Linares; Arnd Hengstermann; Aaron Ciechanover; Stefan Müller; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

10.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

View more
  20 in total

1.  The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization.

Authors:  Patrick L Leslie; Hengming Ke; Yanping Zhang
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

2.  Dysfunction of the MDM2/p53 axis is linked to premature aging.

Authors:  Davor Lessel; Danyi Wu; Carlos Trujillo; Thomas Ramezani; Ivana Lessel; Mohammad K Alwasiyah; Bidisha Saha; Fuki M Hisama; Katrin Rading; Ingrid Goebel; Petra Schütz; Günter Speit; Josef Högel; Holger Thiele; Gudrun Nürnberg; Peter Nürnberg; Matthias Hammerschmidt; Yan Zhu; David R Tong; Chen Katz; George M Martin; Junko Oshima; Carol Prives; Christian Kubisch
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

3.  Structural studies of antitumor compounds that target the RING domain of MDM2.

Authors:  James Ross Terrell; Sijia Tang; Oluwafoyinsola Omobodunde Faniyi; In Ho Jeong; Jun Yin; Bhavitavya Nijampatnam; Sadanandan E Velu; Wei Wang; Ruiwen Zhang; Ming Luo
Journal:  Protein Sci       Date:  2022-08       Impact factor: 6.993

4.  Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo.

Authors:  Vinod Pant; Neeraj K Aryal; Shunbin Xiong; Gilda P Chau; Natalie W Fowlkes; Guillermina Lozano
Journal:  Cancer Res       Date:  2022-04-01       Impact factor: 13.312

5.  On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study.

Authors:  Karim M ElSawy; Chandra S Verma; Thomas L Joseph; David P Lane; Reidun Twarock; Leo S D Caves
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

6.  Mdm2 in evolution.

Authors:  David P Lane; Chandra Verma
Journal:  Genes Cancer       Date:  2012-03

7.  Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.

Authors:  Nien-Pei Tsai; Julia R Wilkerson; Weirui Guo; Marina A Maksimova; George N DeMartino; Christopher W Cowan; Kimberly M Huber
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

Review 8.  MDM2 oligomers: antagonizers of the guardian of the genome.

Authors:  P L Leslie; Y Zhang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

9.  Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.

Authors:  Koji Nomura; Marta Klejnot; Dominika Kowalczyk; Andreas K Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2017-05-29       Impact factor: 15.369

10.  Length matters: C-terminal tails regulate Mdm2-MdmX complexes.

Authors:  Masha V Poyurovsky
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.